---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-072011"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2022-03-10T23:59:59+00:00"
generated_at: "2026-06-27T00:00:34.646751+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Fulcrum Therapeutics eliminates VP Finance role; appoints Gregory Tourangeau as principal accounting officer

## Summary
- Effective March 11, 2022, Peter Thomson terminated as principal accounting officer due to elimination of VP Finance & Accounting position.
- Mr. Thomson remains employed in a transitional capacity through April 1, 2022.
- Gregory Tourangeau, currently Controller, appointed as principal accounting officer effective March 11, 2022.

## SEC filing metadata
- accession: 0001193125-22-072011
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2022-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312522072011/0001193125-22-072011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312522072011/d306646d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-072011
- JSON: https://secwatch.observer/filing/0001193125-22-072011.json
- Plain text: https://secwatch.observer/filing/0001193125-22-072011.txt

## Key facts
- Executive change
  Peter Thomson was terminated as Principal Accounting Officer at Fulcrum Therapeutics, Inc..
  - Action: terminated
  - Role: Principal Accounting Officer
  source text: On March 4, 2022, Fulcrum Therapeutics, Inc. (“Fulcrum”) notified Mr. Peter Thomson of the elimination of the Vice President, Finance & Accounting position and, as a consequence, the termination of his role as Fulcrum’s principal accounting officer, effective as of March 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680581/000119312522072011/0001193125-22-072011-index.htm
- Executive change
  Gregory Tourangeau was appointed as Principal Accounting Officer at Fulcrum Therapeutics, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: Fulcrum appointed Mr. Gregory Tourangeau, Fulcrum’s Controller, as principal accounting officer effective March 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680581/000119312522072011/0001193125-22-072011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.